For the reported quarter, The company delivered adjusted loss of $0.16 per share, surpassing Wall Street estimates of loss of $0.20 per share even as results declined 6.7 percent from a year earlier.
The enterprise generated quarterly revenue of $4.31 million, falling short of analyst expectations of $4.53 million despite year-over-year growth of 52.8% .
Erez Meltzer, Chief Executive Officer and Acting Chairman, said, “We’ve altered our approach to emphasize partnerships, prioritize deployments at high-visibility reference sites like RadNet, and began taking efficiency steps to improve our cost structure. While changing the standard of care in medical imaging takes time, we believe these adjustments position us more effectively for sustainable growth and to capitalize on the potential of Nanox.ARC.”
